ZBH
ZIMMER BIOMET HOLDINGS, INC.
NYSE · Healthcare · Medical - Devices · US
$93.49
+1.14%Price chart
Aug 12Aug 17Aug 20Aug 25Aug 28Sep 2Sep 8Sep 11
ValuationView details →
P/E (Fwd)
10.7x
EV/EBITDA
12.8x
Market Cap
$17.83B
MomentumView details →
1D Return
+1.14%
YTD Return
+2.66%
RSI (14)
36.2
ValuationView details →
P/E (Fwd)
10.7x
EV/EBITDA
12.8x
Market Cap
$17.83B
RSI (14)
36.2
MomentumView details →
1D Return
+1.14%
YTD Return
+2.66%
SummaryUpdated Jun 1, 2026
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is a leading global medical device company specializing in musculoskeletal healthcare solutions. Founded in 1927 and headquartered in Warsaw, Indiana, the company emerged from the merger of Zimmer Holdings and Biomet in 2015. Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive products, surgical instruments, and related technologies used to treat patients with bone, joint, and soft tissue disorders or injuries.
Similar companies
Latest newsMore news →
Zimmer Biomet announced that Kevin Thornal will depart as Group President of Global Businesses and the Americas, effective September 30, 2026, with severance of twelve months' salary and bonus plus COBRA premiums.5d agoZimmer Biomet announced leadership promotions in its Americas commercial organization, promoting Gary Campbell to President, Americas; Brian Hatcher to President, Recon, S.E.T., CMFT, Neuro and Biosurgery; and Bradley Kessler to President, Americas – Robotics, Technology and Data.5d agoZimmer Biomet will relocate its global headquarters to 1800 W. Center Street in Warsaw, the largest orthopedic manufacturing facility in the world.10d ago